Health

World Heart Day

September 29. It is celebrated World Heart Day. It is time, for those who have not yet done so, to make the right commitments to preserve the heart itself and blood vessels. And we have to deal with cholesterol, one of the main negative players in cardiovascular diseases, which in our country accounts for 34.8% of deaths. It is therefore necessary to act. As soon as possible.

This was remembered by the experts of the Italian Heart Foundation, the Italian Society of Cardiology (SIC), the National Association of Hospital Cardiologists (ANMCO) and Conacuore. The opportunity is offered by a survey conducted by SWG on over 1200 adults for Sanofi, which reveals the difficult relationship between Italians and cholesterol and insufficient attention to targeted prevention for each person.

We focus on good habits and targeted treatments

According to 92% of respondents cardiovascular problems they can be avoided with prevention. But unfortunately this consolidated belief does not correspond to concrete prevention and control actions: only for 17% of the sample, in fact, it is advisable to periodically carry out check-ups, while only 31% underwent a cardiovascular risk assessment in the last 12 months.

However, more than others, patients with high cardiovascular risk are unable to escape regular checks and represent, according to international guidelines, the real and urgent priority in the context of preventive interventions. According to Giuseppe Ciancamerla di Conacuore “it is necessary to overcome the preconception that cholesterol can only be fought with diet. It is clear that this can help, but hypercholesterolemia is a pathology, it is called atherosclerosis, and must be treated with the help of a specialist. For this reason, patients need to be increasingly aware of the need for know the various types of cholesterol and their optimal values with the help of risk cards, which are easy to read and correct an inadequate lifestyle.

Even more so if we are talking about a patient with a high cardiovascular risk, in order to maintain adherence to therapy and thus counteract mortality. A traumatic health event such as a heart attack can in fact have physical, but also emotional, devastating effects. In some cases, the specialist plays a pivotal role because he is called to evaluate the involvement of other figures, through a multidisciplinary approach, for a global management of the high-risk patient. In short, for each one a specific prevention path is needed. Also and above all in the case of secondary prevention, that is, there have already been events such as heart attacks or strokes.

See also  The secret of happiness? The happiest man in the world reveals it

How to keep cholesterol at very low levels

The patient at high cardiovascular risk has undergone one or more cardiovascular events and is a chronic patient who must be treated as such. Although he is often on oral medications such as statins and ezetimibe, he can continue to have high levels of LDL, or “bad” cholesterol.

According to Giuseppe Di Tano, of the National Association of Hospital Cardiologists (ANMCO) “for a correct and appropriate care and management of patients with known cardiovascular disease at high risk of events, various actions must be implemented, also through a more effective synergy between primary care, hospital and territory. The control of risk factors through an incisive and early pharmacological intervention, constant monitoring of clinical conditions, sensitization of the patient, of his family-social environment and of the caregiver on the importance of adherence to therapy and lifestyle norms recommended, are fundamental elements capable of counteracting the risk of undergoing a new cardiovascular episode “.

As in primary prevention, also in that secondary it is essential to promote the patient’s primary commitment in the care path, so as to encourage greater proactivity in the management of their health, in relation to the Health System. Failure or inappropriate management of hypercholesterolemia leads, in fact, to a worsening of the state of health and exposure for the patient to a high risk of events, with negative repercussions not only on health but also on the NHS.

“It is a condition as silent as it is insidious as hypercholesterolemia it must be treated in an incisive and precocious way – says Di Tano. This is why it must be attacked with an even more energetic approach than what was done until yesterday, so as to ensure effective risk containment. Finally, the possibility, as indicated by the Guidelines, of using an objective and easily obtainable parameter such as the measurement of blood LDL on which to modulate the therapy, aiming to reach the required target levels, represents an unavoidable recommendation to which to adapt “.

See also  Insomnia, a quick and effective trick to fall asleep easily

Emanuela Folco – Italian Foundation for the Heart (FIPC)

“In our country, over 1 in 3 deaths is attributable to cardiovascular diseases, the leading cause of death for both men (31.7%) and women (37.7%). Anyone who survives a heart attack becomes chronically ill. The disease changes the quality of life and involves significant economic costs for society. In Italy, the prevalence of citizens living with cardiovascular disability is equal to 4.4 per thousand. This is partly attributable to the increase in life expectancy, with an increasingly elderly and therefore ‘fragile’ population, as well as to the prevalence of cardiovascular risk factors, including hypercholesterolemia. After almost three years of pandemic, cardiovascular diseases still do not occupy the first places among the diseases to be feared, given in contrast to what we see in everyday life where mortality from cardiovascular causes occupies the very first places.

Today is an opportunity to reiterate, once again, the importance of raising awareness among citizens and patients to take their cardiovascular health to heart starting from primary prevention, emphasizing as always the need to adopt correct lifestyles and a healthy nutrition, but also and above all secondary where there is a pathological condition that needs to be taken in charge by the specialist. ”

And it is precisely through prevention that, for 92% of the interviewees, cardiovascular problems can be avoided. However, this consolidated belief does not correspond to concrete prevention and control actions: only for 17% of the sample, in fact, it is advisable to periodically carry out check-ups, while only 31% underwent a cardiovascular risk assessment in the last 12 months.

However, more than others, patients with high cardiovascular risk are unable to escape regular checks and represent, according to international guidelines, the real and urgent priority in the context of preventive interventions.

Ciro Indolfi – Italian Society of Cardiology (SIC)

“The issue of prevention is of great importance for all of us, but it becomes crucial when it comes to patients with high cardiovascular risk: those who have been affected by a cardiovascular event, in fact, run a high risk of suffering a new heart attack or stroke. in subsequent years. Events that could be significantly reduced – as the recent guidelines of the European Society of Cardiology recall – if secondary prevention strategies were increasingly implemented.

See also  Megalophobia: what it is and how to deal with it

The lowering of LDL cholesterol thresholds for access to the new PCSK9 anti-cholesterol drugs, recently published in the Official Journal by AIFA, goes precisely in the direction of an early and rapid treatment. Scientific evidence shows that LDL cholesterol is the cause of cardiovascular diseases, not a risk factor, and how its reduction – therefore – represents one of the main objectives for limiting cardiovascular events such as myocardial infarction and counteracting mortality. In fact, the guidelines of the European Society of Cardiology suggest LDL cholesterol levels below 55 mg / dl in secondary prevention and, in some particularly at risk patients, even lower LDL-C levels and below 40 mg / dl. These ambitious goals can now be achieved thanks to the PCSK9 protein inhibitors, capable of reducing the LDL cholesterol level by 60%, demonstrating a clear clinical benefit in patients with high cardiovascular risk. A change of course, the one started for the first time in Italy compared to other European countries, for the secondary prevention of cardiovascular diseases “.

Andrea Rizzi – Medical Head General Medicines of Sanofi Italy

“At Sanofi we are daily engaged in the study of innovative therapeutic solutions and programs to improve the quality of life and survival of patients with cardiovascular diseases. It is a concrete commitment that is also expressed in a contribution in terms of raising public awareness, patients and caregivers, on how the level of attention related to the impact that this type of diseases have on our society and on the national health system should be raised. . At Sanofi we work alongside associations that represent patients and the medical profession, to help drastically reduce the impact in terms of mortality and quality of life that cardiovascular diseases still have today, offering concrete answers in terms of treatments and therapies and management in the field of secondary prevention with particular attention to high-risk patients “.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button